Jim Cramer says these 10 ‘old guard’ stocks are making a comeback

Jim Cramer says these 10 ‘old guard’ stocks are making a comeback


CNBC’s Jim Cramer on Tuesday offered investors a list of 10 companies that he believes are rising to the top as tech stocks collapse.

“It’s the revenge of the old guard right now, right here. All sorts of boring, conventional companies are taking back the market while the digitizers and disruptors are being burned,” he said.

Here is his list:

  1. Johnson & Johnson
  2. Eli Lilly
  3. Boeing
  4. Honeywell
  5. Raytheon
  6. Caterpillar
  7. Deere & Co
  8. PepsiCo
  9. Starbucks
  10. Nucor 

Cramer also warned that many investors refuse to embrace the “new reality” of the market’s distaste for tech stocks. He attributed the collapse of tech stocks largely to the plethora of competition in the industry.

Microsoft‘s Azure goes up against Amazon Web Services, which goes up against Google Cloud. Netflix now competes with half a dozen streaming services,” he said.

He added that the companies he mentioned are the opposite of tech firms struggling to differentiate themselves from industry peers: “Companies that don’t have much competition, or at least the competition’s so muted that it can’t disrupt the status quo.”

Disclaimer: Cramer’s Charitable Trust owns shares of Amazon, Alphabet, Johnson & Johnson, Eli Lilly, Honeywell, Microsoft and Starbucks.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Major League Baseball names Polymarket exclusive prediction market partner
Business

Major League Baseball names Polymarket exclusive prediction market partner

Shayne Coplan, chief executive officer of Polymarket, on the floor of the New York Stock Exchange (NYSE) in New York, US, on Thursday, Nov. 13, 2025. Michael Nagle | Bloomberg | Getty Images Major League Baseball on Thursday announced it was naming Polymarket its official prediction market partner. The association also signed a memorandum of […]

Read More
Real estate could be the big winner in the private credit exodus
Business

Real estate could be the big winner in the private credit exodus

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Barely […]

Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Business

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight.  The drug lowered hemoglobin A1c — a key measure of blood sugar levels — by an average of 1.7% to 2% across different doses at […]

Read More